RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. A19/231a
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 124
2010
-
Nf449 is a novel inhibitor of fibroblast growth factor receptor 3 (fgfr3) signaling active in chondrocytes and multiple myeloma cells
J. Biol. Chem., year: 2010, volume: 285, edition: 27, DOI
2009
-
FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway
Human Molecular Genetics, year: 2009, volume: 18, edition: 2
-
Fibroblast growth factor inhibits interferon gama-STAT1 and interleukin 6-STAT3 signaling in chondrocytes
Cellular Signalling, year: 2009, volume: 21, edition: 1, DOI
-
High molecular weight FGF2: the biology of a nuclear growth factor
Cellular and molecular life sciences : CMLS, year: 2009, volume: 66, edition: 2, DOI
-
Molecular pathology of the fibroblast growth factor family.
Human Mutation, year: 2009, volume: 30, edition: 9, DOI
2008
-
A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells
HUMAN MOLECULAR GENETICS, year: 2008, volume: 18, edition: 11
-
Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage
PLoS ONE., year: 2008, volume: 3, edition: 12
-
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
JOURNAL OF CELL SCIENCE, year: 2008, volume: 121, edition: 3
2007
-
C-natriuretic peptide: an important regulator of cartilage.
Molecular Genetics and Metabolism, year: 2007, volume: 92, edition: 3, DOI
-
Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligandsexpressed in human fetal growth plate cartilage.
Pediatric Research, year: 2007, volume: 61, edition: 3, DOI